Foghorn Therapeutics competitors and similar companiesClear all

Foghorn Therapeutics's competitors and similar companies include Nurix, Kymera Therapeutics, Arvinas and Ultivue.
Foghorn Therapeutics
Foghorn Therapeutics
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
Nurix
Nurix
Nurix, Inc. is a leader in discovering and developing a new class of drugs that work by modulating the protein regulation machinery of the cell.
Kymera Therapeutics
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
Arvinas
Arvinas
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
Ultivue
Ultivue
Ultivue operates in the biotechnology industry.
Founding Date
Founding Date
2016
Founding Date
2009
Founding Date
2017
Founding Date
N/A
Founding Date
2015
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Cambridge, US HQ
Cambridge, US
Locations
San Francisco, US HQ
Locations
Watertown, US HQ
Cambridge, US
Locations
New Haven, US HQ
Locations
Cambridge, US HQ
Segrate, IT
Employees
Employees
85
Employees
2963% increase
Employees
177
Employees
13329% increase
Employees
894% decrease
Valuation ($)
Valuation ($)
365.7 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
1.7 b
Valuation ($)
N/A
Twitter followers
Twitter followers
986
Twitter followers
N/A
Twitter followers
2.9 k
Twitter followers
2.9 k
Twitter followers
492
Number of tweets (last 30 days)
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
23
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
4
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
6.9
Average likes per tweet (last 30 days)
2.9
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
82.61%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
246067
Alexa Website Rank
687942
Alexa Website Rank
444362
Alexa Website Rank
426928
Alexa Website Rank
557927
Employee Rating
Employee Rating
4.2
Employee Rating
4.1
Employee Rating
4.4
Employee Rating
4.7
Employee Rating
3.1

Financial

Revenue (est.)
Revenue (est.)
$1.3m (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$46.7m (FY, 2021)
Revenue (est.)
N/A
Net income
Net income
($101.3m) (FY, 2021)
Net income
N/A
Net income
N/A
Net income
($196.2m) (FY, 2021)
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 120m (almost 3 years ago)
Latest funding round
$ 102m (almost 3 years ago)
Latest funding round
N/A
Latest funding round
$ 22m (over 3 years ago)
Total funding raised
Total funding raised
$ 50m
Total funding raised
$ 165.2m
Total funding raised
$ 197m
Total funding raised
$ 111.6m
Total funding raised
$ 57.3m
For sources of this data, please see the company profile

View company profiles

Nurix
HQ
San Francisco, US
Employees
296↑ 3% increase

Nurix, Inc. is a leader in discovering and developing a new class of drugs that work by modulating the protein regulation machinery of the cell.

View company
Kymera Therapeutics
HQ
Watertown, US
Employees
177

Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.

View company
Arvinas
HQ
New Haven, US
Employees
133↑ 29% increase

Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.

View company
Ultivue
HQ
Cambridge, US
Employees
89↓ 4% decrease

Ultivue operates in the biotechnology industry.

View company